Harald zur Hausen, PhD, a German virologist who won the 2008 Nobel Prize in Medicine for his discovery that human papillomavirus caused cervical cancer, died May 29 at 87, The New York Times reported June 9.

Oncologist pay and volume is up 13 percent, but 35 percent of oncologists still take extra work, a Medscape survey found.

Miami-based Sylvester Comprehensive Cancer Center researchers found federal cancer research funding is heavily allocated to cancers that occur more often in white people than other racial groups.

The Moores Cancer Center at UC San Diego Health is revamping its clinical trials right as its director is stepping down for personal reasons, the La Jolla Light reported June 7.

Cancer survivors in the United States who report diminished quality of life "more than doubled" in the past two decades, according to a study published May 11 in JAMA Oncology.

Tampa-based Moffitt Cancer Center appointed Xavier Avat as chief business officer, the Business Observer reported June 5.

Continuing immunotherapy treatments when a renal cancer patient's disease has progressed may actually do more harm than good, according to results of a new study from Los Angeles-based City of Hope researchers. 

Some patients with locally advanced rectal cancer may be able to safely forgo radiation before surgery to remove tumors, according to research published June 4 in The New England Journal of Medicine and the Journal of Clinical Oncology. 

Grail, a company that developed blood tests to detect cancer, mistakenly sent approximately 400 customers letters saying they might be positive for the disease, The New York Times reported June 4.

GenesisCare, a global cancer and cardiac care service provider, has filed for Chapter 11 bankruptcy, according to a June 1 press release.

Here are the 10 most-read oncology stories published by Becker's in May:

Some immunotherapies and small molecule kinase inhibitors have been shown to cause "major fungal infections," according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.

Some immunotherapies and small molecule kinase inhibitors have been shown to cause "major fungal infections," according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.

Screenings that were delayed due to COVID-19 are likely to contribute to an exponential increase in cancer diagnosis totals over the next few years, experts say.

Some critics are speaking out against the U.S. Preventive Services Task Force's recommendation to lower the mammogram screening age to 40, KFF Health News reported May 30.

A study led by researchers from Hadassah-University Medical Center in Jerusalem found a 90 percent success rate in treating multiple myeloma and putting patients into remission, the Jerusalem Post reported May 29. 

Some oncologists are rationing cancer drugs and delaying patient treatment as the shortages grow worse, NBC News reported May 28.

Patients with recurrent low-grade serous ovarian cancer had an 86 percent reduction in tumor size in a new study led by Verastem Oncology, according to a May 25 news release. 

Hospitals and systems across the country are opening and expanding their oncology services, and many more are working to add, consolidate or expand their cancer services to meet demand.

St. Joseph's Health and Hackensack Meridian Health opened a new cancer center in Totowa, N.J., on May 25.